{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:43:51Z","timestamp":1790775831273,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.2515\/therapie:2005017","type":"journal-article","created":{"date-parts":[[2007,3,12]],"date-time":"2007-03-12T08:04:34Z","timestamp":1173686674000},"page":"125-136","source":"Crossref","is-referenced-by-count":5,"title":["Le fibrinog\u00e8ne a-t-il une place pour \u00e9valuer le risque d\u2019accident cardiovasculaire isch\u00e9mique ?"],"prefix":"10.1016","volume":"60","author":[{"given":"Ludovic","family":"Drouet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire Bal dit","family":"Sollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2005017_bb0630","first-page":"85","article-title":"Blood coagulation and fibrinolysis in obese NIDDM patients","volume":"25","author":"Avellone","year":"1994","journal-title":"Diabetes Res"},{"key":"10.2515\/therapie:2005017_bb0635","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1055\/s-0037-1615362","article-title":"Fibrinogen plasma levels in an apparently healthy general population: relation to environmental and genetic determinants","volume":"80","author":"Margaglione","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie:2005017_bb0640","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1749-6632.2001.tb03537.x","article-title":"Effects of diet, drugs, and genes on plasma fibrinogen levels","volume":"936","author":"de Maat","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.2515\/therapie:2005017_bb0645","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/oxfordjournals.aje.a010203","article-title":"Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen","volume":"151","author":"Wu","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.2515\/therapie:2005017_bb0650","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/ndt\/15.11.1835","article-title":"Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients","volume":"15","author":"Park","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.2515\/therapie:2005017_bb0655","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"10.2515\/therapie:2005017_bb0660","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0021-9150(91)90167-2","article-title":"Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors","volume":"91","author":"Folsom","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.2515\/therapie:2005017_bb0665","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.19.7.1776","article-title":"The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study","volume":"19","author":"Tracy","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0670","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0735-1097(99)00007-8","article-title":"A prospective study of fibrinogen and risk of myocardial infarction in the Physicians\u2019 Health Study","volume":"33","author":"Ma","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.2515\/therapie:2005017_bb0675","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/aje\/152.5.420","article-title":"Plasma fibrinogen and coronary heart disease in urban Japanese","volume":"152","author":"Sato","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.2515\/therapie:2005017_bb0680","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.102.23.2816","article-title":"Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease","volume":"102","author":"Cooper","year":"2000","journal-title":"Circulation"},{"key":"10.2515\/therapie:2005017_bb0685","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001721-200011010-00005","article-title":"Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study","volume":"11","author":"Smith","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.2515\/therapie:2005017_bb0690","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.ATV.19.6.1368","article-title":"Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update","volume":"19","author":"Maresca","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0695","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198408233110804","article-title":"Fibrinogen as a risk factor for stroke and myocardial infarction","volume":"311","author":"Wilhelmsen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2005017_bb0700","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease: The Framingham Study","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"},{"key":"10.2515\/therapie:2005017_bb0705","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1161\/01.ATV.17.11.3321","article-title":"Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study","volume":"17","author":"Smith","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0710","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation"},{"key":"10.2515\/therapie:2005017_bb0715","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1067\/mhj.2001.118118","article-title":"Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age","volume":"142","author":"Gattone","year":"2001","journal-title":"Am Heart J"},{"key":"10.2515\/therapie:2005017_bb0720","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-7125(05)70211-X","article-title":"C-reactive protein, inflammation, and coronary risk","volume":"84","author":"Morrow","year":"2000","journal-title":"Med Clin North Am"},{"key":"10.2515\/therapie:2005017_bb0725","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2005017_bb0730","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/rheumatology\/40.6.640","article-title":"Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis","volume":"40","author":"McEntegart","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.2515\/therapie:2005017_bb0735","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.ATV.15.9.1263","article-title":"Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors","volume":"15","author":"Levenson","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0740","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/hy1101.095335","article-title":"Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study","volume":"38","author":"Palmieri","year":"2001","journal-title":"Hypertension"},{"key":"10.2515\/therapie:2005017_bb0745","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0037-1615917","article-title":"Gene-environment interaction in the determination of levels of plasma fibrinogen","volume":"82","author":"Humphries","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie:2005017_bb0750","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0037-1614523","article-title":"Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study","volume":"81","author":"Lee","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie:2005017_bb0755","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.CIR.93.3.440","article-title":"Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-T\u00e9moins sur l\u2019Infarctus du Myocarde","volume":"93","author":"Behague","year":"1996","journal-title":"Circulation"},{"key":"10.2515\/therapie:2005017_bb0760","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.ATV.17.2.246","article-title":"Polymorphisms of factor V, factor VII, and fibrinogen genes: relevance to severity of coronary artery disease","volume":"17","author":"Wang","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0765","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.18.2.265","article-title":"455G\/A polymorphism of the betafibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen: REGRESS group","volume":"18","author":"de Maat","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0770","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2141.2000.02266.x","article-title":"Fibrinogen polymorphisms are not associated with the risk of myocardial infarction","volume":"110","author":"Doggen","year":"2000","journal-title":"Br J Haematol"},{"key":"10.2515\/therapie:2005017_bb0775","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/01.ATV.18.3.487","article-title":"Beta-fibrinogen gene polymorphism (C148-->T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study","volume":"18","author":"Schmidt","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0780","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-0037-1616235","article-title":"Haemostatic genetic risk factors in arterial thrombosis","volume":"86","author":"Simmonds","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie:2005017_bb0785","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1172\/JCI119499","article-title":"A common mutation (G-455-->A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease: a study of 9127 individuals based on the Copenhagen City Heart Study","volume":"99","author":"Tybjaerg-Hansen","year":"1997","journal-title":"J Clin Invest"},{"key":"10.2515\/therapie:2005017_bb0790","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1161\/01.ATV.17.12.3489","article-title":"Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels: a case-control study in a sample of GISSI-2 patients","volume":"17","author":"Zito","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0795","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/hy1101.099478","article-title":"Genes encoding fibrinogen and cardiovascular risk","volume":"38","author":"Iacoviello","year":"2001","journal-title":"Hypertension"},{"key":"10.2515\/therapie:2005017_bb0800","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1749-6632.2001.tb03550.x","article-title":"Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cells","volume":"936","author":"Mirshahi","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl. 1","key":"10.2515\/therapie:2005017_bb0805","first-page":"S35","article-title":"Plasma gamma\u2019\/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?","volume":"10","author":"Drouet","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl. A","key":"10.2515\/therapie:2005017_bb0810","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/eurheartj\/16.suppl_A.6","article-title":"Biochemistry and measurement of fibrinogen","volume":"16","author":"Nieuwenhuizen","year":"1995","journal-title":"Eur Heart J"},{"key":"10.2515\/therapie:2005017_bb0815","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0038-1650618","article-title":"Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age","volume":"76","author":"Fatah","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie:2005017_bb0820","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1182\/blood.V82.7.2117.2117","article-title":"Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: identification of polymorphisms at positions A alpha 312 and B beta 448","volume":"82","author":"Baumann","year":"1993","journal-title":"Blood"},{"key":"10.2515\/therapie:2005017_bb0825","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1055\/s-0037-1615121","article-title":"The alpha fibrinogen T\/A312 polymorphism in the ECTIM study","volume":"79","author":"Curran","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie:2005017_bb0830","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/euhj.1999.1699","article-title":"Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease","volume":"21","author":"Danesh","year":"2000","journal-title":"Eur Heart J"},{"issue":"2","key":"10.2515\/therapie:2005017_bb0835","first-page":"667","article-title":"Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events","volume":"82","author":"Lowe","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.2515\/therapie:2005017_bb0840","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/euhj.1997.0573","article-title":"Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study","volume":"19","author":"Woodward","year":"1998","journal-title":"Eur Heart J"},{"key":"10.2515\/therapie:2005017_bb0845","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.ATV.16.3.351","article-title":"Fibrinogen is a predictor of mortality in coronary heart disease patients: The Bezafibrate Infarction Prevention (BIP) Study Group","volume":"16","author":"Benderly","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie:2005017_bb0850","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001721-199801000-00005","article-title":"The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial","volume":"9","author":"Dimmitt","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.2515\/therapie:2005017_bb0855","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/hc3701.096067","article-title":"Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort","volume":"104","author":"Mukamal","year":"2001","journal-title":"Circulation"},{"key":"10.2515\/therapie:2005017_bb0860","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0021-9150(00)00734-6","article-title":"Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study: Prospective Epidemiological Study of Myocardial Infarction Study","volume":"157","author":"Marques-Vidal","year":"2001","journal-title":"Atherosclerosis"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716302773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716302773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T20:50:22Z","timestamp":1587415822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716302773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0040595716302773"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2005017","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}